Related by context. Frequent words. (Click for all words.) 59 ISIS # 58 RDEA# 57 preclinical 57 ALN VSP 57 INCB# [002] 57 BiTE antibody 57 XL# [003] 56 GRN#L 56 MB# [004] 56 anti angiogenic 56 CA4P 56 preclinical studies 56 NGX# 56 oral bioavailability 56 Homspera 56 AACR NCI EORTC 55 ANAVEX #-# [003] 55 Phase 2a trial 55 antitumor 55 MLN# 55 humanized monoclonal antibody 55 AP# [003] 55 IMGN# 55 laquinimod 55 TLR7 55 blinatumomab 55 pharmacodynamic 55 preclinical models 55 Atiprimod 54 DG# [001] 54 HGS ETR1 54 potent inhibitor 54 MGCD# [001] 54 CYT# 54 LymphoStat B 54 ENMD 54 AEOL # 54 CoFactor 54 perifosine 54 neuroprotective 54 PRX # 54 Debio 54 pharmacokinetic properties 53 ZYBRESTAT 53 antitumor activity 53 lupus nephritis 53 CK # 53 Preclinical studies 53 MDV# 53 AEZS 53 CUDC 53 MOR# 53 JAK2 52 BAY #-# 52 Phase IIa clinical 52 Marqibo 52 Phase 2a clinical 52 CB# [002] 52 HspE7 52 vivo 52 antisense drug 52 immunomodulatory 52 Hedgehog pathway 52 ONCONASE 52 epratuzumab 51 Locteron 51 tesetaxel 51 bevirimat 51 antisense drugs 51 TREANDA 51 PBT2 51 pharmacokinetic 51 castration resistant prostate cancer 51 Perifosine 51 elesclomol 51 Phase 2b trial 51 CBLB# 51 GSK # 51 Phase IIa trial 51 IDX# 51 hematological malignancies 51 INGN 51 PF # [001] 51 phase IIb 51 Phase IIb clinical 51 TLR9 51 antiviral activity 51 NKTR 50 APD# 50 ALN RSV# 50 HDAC inhibitor 50 AZD# 50 calcitonin 50 multiple ascending dose 50 eculizumab 50 Opexa 50 immunogenicity 50 Alpharadin 50 ATryn R 50 pharmacokinetic profile 50 ADX#